US FDA tells doctors to temporarily stop using Rotarix
This article was originally published in Scrip
Executive Summary
The US FDA has recommended that physicians in the US temporarily suspend use of GlaxoSmithKline's Rotarix oral vaccine for rotavirus immunisations due to concerns over viral contamination with porcine circovirus-1 (PCV-1).